Genome Sequencing of Rare Disease Patients Through the Korean Regional Rare Disease Diagnostic Support Program
Human Mutation · 2025-01 · 2025 (1)
DOI: 10.1155/humu/6096758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 27.02.2025. Verfasst von Rin Khang und 25 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Division, 3billion Inc., Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Rare Diseases, Whole Genome Sequencing. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
Affecting fewer than 20,000 people as defined in South Korea, rare diseases pose significant diagnostic challenges due to their diverse manifestations and genetic heterogeneity. Genome sequencing (GS) offers a promising solution by enabling simultaneous screening for thousands of rare genetic disorders. This study explores the diagnostic utility and necessity of GS within the government‐funded Korean Regional Rare Disease Diagnostic Support Program (KR‐RDSP), a collaborative initiative involving 11 regional rare disease centers across Korea. The program was launched as a proof‐of‐concept study in 2023 to equip the genetic clinics with a diagnostic tool to expedite the diagnoses for rare disease patients who reside outside the urban Seoul region where diagnostic resources are limited. The study leveraged GS to diagnose a cohort of 400 patients exhibiting a wide spectrum of symptoms. The overall diagnostic yield was 36.3% (145/400), with 4.8% (7/145) of the diagnosed patients being reported with variants that could not have been identified by chromosomal microarray or exome sequencing (ES), highlighting the added value of comprehensive genomic analysis. The implementation of a centralized GS analysis system streamlined the diagnostic process, enabling timely reporting within a reasonable turnaround time of ≤ 35 days. Segregation analysis by Sanger sequencing played a crucial role in confirming or reclassifying variant pathogenicity by elucidating inheritance patterns. Here, we summarize diagnostic statistics from the 400 GS dataset gathered from June 2023 to December 2023 and show interesting and informative case examples that illustrate the diagnostic efficacy of GS, highlighting its ability to uncover elusive genetic etiologies and provide personalized treatment insights. The study also highlights the successful implementation of the program for the 11 regional rare disease centers across Korea with a practical workflow, comprehensive testing, comparable diagnostic yield to previous reports, and, most importantly, reasonable turnaround time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Medical Genetics Division, 3billion Inc., Seoul, Republic of Korea.
- Research and Development Center, 3billion Inc., Seoul, Republic of Korea.
- Rare Disease Center of Southern Gyeonggi Region, Department of Medical Genetics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Republic of Korea.
- Rare Disease Center of Chungbuk Region, Department of Pediatrics, Chungbuk National University Hospital, Cheongju, Republic of Korea.
- Rare Disease Center of Northwestern Gyeonggi Province, Department of Pediatrics, Inha University Hospital, Incheon, Republic of Korea.
- Rare Disease Center of Gangwon Region, Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea.
ORCID-Profile: Rin Khang, Hane Lee, Jihye Kim, Dongseok Moon, Seokhui Jang, Eugene Lee, Yongjun Song, Seung Woo Ryu, Sohyun Lee, Heonjong Han, Sukwon Kim, Sohyun Jang, Ji-Eun Lee, Go Hun Seo, Seung Hwan Oh, Chong Kun Cheon
Förderung
- Korea Disease Control and Prevention Agency
Zitieren
APA
Khang, R., Lee, H., Kim, J., Moon, D., Jang, S., Lee, E., Song, Y., Ryu, S. W., Lee, S., Han, H., Kim, S., Jang, S., Sohn, Y. B., Kim, W. S., Lee, J. E., Kim, J., Cho, Y., Lee, B. L., Lim, H. H., …, & Cheon, C. K. (2025). Genome Sequencing of Rare Disease Patients Through the Korean Regional Rare Disease Diagnostic Support Program. Human Mutation, 2025(1). https://doi.org/10.1155/humu/6096758
Vancouver
Khang R, Lee H, Kim J, Moon D, Jang S, Lee E, et al. Genome Sequencing of Rare Disease Patients Through the Korean Regional Rare Disease Diagnostic Support Program. Human Mutation. 2025;2025(1). doi:10.1155/humu/6096758
BibTeX
@article{Khang2025,
author = {Khang, Rin and Lee, Hane and Kim, Jihye and Moon, Dongseok and Jang, Seokhui and Lee, Eugene and Song, Yongjun and Ryu, Seung Woo and Lee, Sohyun and Han, Heonjong and Kim, Sukwon and Jang, Sohyun and Sohn, Young Bae and Kim, Won Seop and Lee, Ji-Eun and Kim, Juwon and Cho, Yonggon and Lee, Bo Lyun and Lim, Han Hyuk and Kook, Hoon and Kang, Ki-Soo and Kwon, Soonhak and Lee, Jiwon and Seo, Go Hun and Oh, Seung Hwan and Cheon, Chong Kun},
title = {Genome Sequencing of Rare Disease Patients Through the Korean Regional Rare Disease Diagnostic Support Program},
journal = {Human Mutation},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/humu/6096758}
}
EUVIMED